Rajesh Narendran

NeuroscienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Imaging beta-amyloid (Aβ) burden in the brains of middle-aged individuals with alcohol-use disorders: a [11C]PIB PET study”.

Imaging beta-amyloid (Aβ) burden in the brains of middle-aged individuals with alcohol-use disorders: a [11C]PIB PET study

Translational Psychiatry(2021)10.1038/s41398-021-01374-y

N/A

0.629DataRank · unranked

16 citations

Sarah K. Royse, David P. Cenkner, Katelyn M. Kozinski, Clara Stoughton, Michael L. Himes +5 more

Imaging the Influence of Red Blood Cell Docosahexaenoic Acid Status on the Expression of the 18 kDa Translocator Protein in the Brain: A [11C]PBR28 Positron Emission Tomography Study in Young Healthy Men

Biological Psychiatry Cognitive Neuroscience and Neuroimaging(2021)10.1016/j.bpsc.2021.09.005

N/A

0DataRank · unranked

4 citations

Michael L. Himes, Katelyn M. Kozinski, Brian J. Lopresti, N. Scott Mason, Joseph R. Hibbeln +3 more

Imaging Nociceptin Opioid Peptide Receptors in Alcohol Use Disorder With [11C]NOP-1A and Positron Emission Tomography: Findings From a Second Cohort

Biological Psychiatry(2023)10.1016/j.biopsych.2022.12.022

N/A

0DataRank · unranked

6 citations

Clara Stoughton, Michael L. Himes, Kaylynn E. McKinney, Scott J. Mason, Roberto Ciccocioppo +2 more

Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.21.550008

N/A

0DataRank · unranked

0 citations

Qianwei Shen, Hongwu Li, Federica Benvenuti, Laura Soverchia, Rajesh Narendran +4 more

Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy

Neuropharmacology(2024)10.1016/j.neuropharm.2024.110048

N/A

0DataRank · unranked

8 citations

Veronica Lunerti, Qianwei Shen, Hongwu Li, Federica Benvenuti, Laura Soverchia +4 more